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Objectives 
• To synthesize the extant evidence regarding the effectiveness of incarceration-
based drug treatment in reducing drug relapse and recidivism.   
• Specifically, this systematic review addressed:  
¾ Are incarceration-based drug treatment programs effective in reducing 
recidivism and drug use?   
¾ Approximately how effective are these programs (i.e., what’s the 
magnitude of the effect)?   
¾ Are there particular types of drug treatment programs that are especially 
effective or ineffective?   
Findings 
• Sixty-six independent evaluations met our eligibility criteria, the most important of 
which was the use of a comparison group.  
• Approximately 83% of recidivism odds-ratios indicated that the drug treatment 
group had less recidivism than the comparison group. The mean odds-ratio was 
1.37, indicating that on average participation in these drug treatment programs 
was associated with a modest reduction in post-treatment offending; assuming a 
35% recidivism rate for the comparison group (which was the average recidivism 
rate for comparison groups), this overall mean odds-ratio translates into a 
recidivism rate of approximately 28% for the treatment group.   
• The effectiveness of drug treatment varied by type of treatment:  
¾ Boot camps aimed at drug involved offenders were ineffective in reducing 
re-offending and drug relapse.  
¾ Narcotic maintenance programs did not exhibit reductions in re-offending 
or drug use, but the evidence in this area was scant. 
¾ Group counseling programs exhibited reductions in re-offending but not 
drug use.  
¾ Therapeutic communities (TCs) exhibited the strong and consistent 
reductions in drug relapse and recidivism. 
Caveats and Qualifications 
• The small number of independent evaluations of narcotic maintenance programs 
undermines our ability to draw firm conclusions about these programs.  
• Many of the included evaluations were methodologically weak, which limits our 
ability to draw firm conclusions from these evaluations. 
• Many of our analyses were limited by low statistical power. 
Implications for Decision Makers 
• Programs that intensively focus on the multiple problems of substance abusers, 
such as TCs, are most likely to reduce drug use and recidivism.   
• Correctional boot camps for drug offenders cannot be justified in terms of 
reduced recidivism.  
Implications for Research  
• Beneficial future research will focus on determining which components of 
effective programs are important and why are such components important. 
• Beneficial future research will employ methodologically rigorous techniques that 
reduce the likely of selection bias and other threats to internal validity. 
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1 Background for the Review 
 
Research indicates that a substantial proportion of incarcerated offenders are 
drug dependent.  Peters and colleagues (Peters, Greenbaum, Edens, Carter, and Ortiz, 
1993) for example, reported that 56% of a sample of Texas inmates were diagnosed as 
having a substance abuse or dependence disorder during the 30 days prior to their 
incarceration.  Similarly, a survey of jail inmates in Ohio found that 51% were currently 
drug dependent (Lo and Stephens, 2000).  In fact, it is estimated that about 40% of all 
Americans who clearly need drug treatment are under the supervision of the criminal 
justice system (Gerstein and Harwood, 1990:7).   
Drug dependence also appears to be common among incarcerated offenders in 
many other countries besides of the United States. While international research 
assessing drug dependence among incarcerated offenders is more limited, the existing 
evidence indicates that drug dependence is common among incarcerated offenders in 
many nations. For instance, Bennett (1998) found that 45% of a sample of incarcerated 
arrestees in five English cities reported being drug dependent at one point in their lives, 
and 33% reported being currently drug dependent. Likewise, 31% of inmates 
incarcerated in Canadian federal prisons and 43% of inmates incarcerated in provincial 
prisons were found to be drug dependent (Pernanen, Cousineau, Brochu, and Sun, 
2002). 
In the absence of effective substance abuse treatment, it is likely that a high 
proportion of these drug dependent offenders will persist in crime. In fact, statistics 
reported by the Bureau of Justice Statistics indicate that among probationers, frequent 
drug abusers were 53% more likely to be re-arrested than non-drug abusers (Bureau of 
Justice Statistics 1995: 26). As such, the period of time when an offender is incarcerated 
represents a crucial opportunity to prevent crime by intervening in the cycle of drug 
abuse and crime.  
Several aspects of correctional facilities (i.e., prisons, jails) make incarceration-
based substance abuse treatment attractive. First, the availability of drugs is more 
limited in correctional facilities than in the community, which facilitates detoxification and 
abstinence during treatment. Second, there is an abundance of time available to focus 
on treatment and introspection. Perhaps most importantly, correctional facilities have the 
capacity to mobilize considerable coercive force to encourage substance abusing 
offenders to engage in treatment, many of whom otherwise would not do so. 
Incarceration-based drug treatment is diverse, encompassing a broad array of 
treatment programs, including group and individual psychotherapy, 12-step programs, 
methadone maintenance and punitive interventions, such as boot camps for drug 
abusing offenders. For our purposes, the defining features of these programs are that 
they target substance abusers, intend to reduce substance abuse and other criminal 
behaviors, and these interventions are based in a correctional facility. Evaluations of 
existing incarceration-based drug treatment programs predominantly focus on assessing 
the effectiveness of therapeutic communities (TCs) and group counseling programs 
(e.g., drug education, 12-step programs, such as AA/NA). A considerably smaller 
number of evaluations have assessed the effectiveness of boot camps targeted 
specifically at substance abusers or narcotic maintenance programs. 
The individual components of TCs vary widely. Yet, several components appear 
to be common. First, in order to create an environment conducive to rehabilitation, 
residents in therapeutic communities are most commonly housed in a separate, distinct 
treatment unit away from non-participating inmates. Second, residents are instrumentally 
involved in running the therapeutic community including leading treatment sessions, 
monitoring other residents for rule compliance, maintaining the treatment unit, and 
resolving disputes. Third, staff and residents of TCs tend to be confrontational with rule 
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violators, but residents also are supportive of each other’s struggles to make positive 
changes. Fourth, the guiding philosophy of TCs is that drug use is symptomatic of more 
general personal disorders, thus the focus of the treatment is on the underlying disorders 
and not drug abuse, per se.  
Counseling programs are somewhat harder to characterize. Generally these 
programs incorporate elements of group counseling programs (e.g., 12-step programs 
such as AA/NA), life skills training, cognitive skills training, drug education, and adult 
basic (academic) education. A key commonality among these programs is their reliance 
on group based therapies, in which substance abuse and other common problems are 
discussed among peers in an effort to solve mutual issues. However, not all counseling 
programs rely on peer therapy; some counseling programs are individual-based where 
the client and a clinician work together to remedy drug problems. And still other 
counseling programs include both group and individual counseling.   
Boot camps are modeled after military basic training. Inmates participate in 
rigorous exercise regimens, learn military drill and ceremony, wear uniforms, and take 
on challenge courses (timed obstacle courses). Boot camps are highly structured. From 
the moment residents wake in the morning until lights out they are constantly engaged in 
scheduled activities. Boots camps also involve considerable confrontation, but unlike 
most TC programs confrontations most often occur between correctional staff and 
inmates—with drill instructors disciplining any deviation from established codes of 
conduct. In theory, the harsh, rigorous nature of boot camp programs serve as a 
deterrent to future criminal conduct, and the content of these programs instill self-
discipline within program participants, which also leads to reduced recidivism (Wilson 
and MacKenzie, 2006). 
Narcotic maintenance programs (i.e., methadone and levo-alpha-acetyl-methadol 
maintenance [LAAM]) are very different than other types of incarceration-based drug 
treatment programs. These programs attempt to reduce the harms associated with 
heroin dependency (e.g., disease transmission, criminal activity) by prescribing synthetic 
opioid medication. Unlike heroin, these medications do not produce a euphoric high; 
instead, methadone and LAAM block the euphoric high produced by opiate use and 
suppress opiate withdrawal symptoms. Some long term narcotic treatments gradually 
reduce the amount of medication administered to the client until the opiate dependence 
is relieved; other programs maintain clients indefinitely.   
Each of the above types of drug interventions ostensibly has the potential to 
reduce drug use and other criminal behaviors. Existing systematic reviews of this body 
of literature, however, only found strong evidence supporting the effectiveness of TC 
programs (Pearson and Lipton, 1999). In particular, Pearson and Lipton (1999) 
systematically reviewed the research assessing the effectiveness of corrections-based 
drug abuse programs in reducing recidivism. Their systematic review conducted a 
comprehensive search for quasi-experimental and experimental evaluations of 
interventions carried out in correctional settings [i.e., “prison, jail, or a similar residential 
correctional facility” (p. 390)], conducted in any country, and completed between 1968 
and 1996, inclusive. Their search revealed 30 studies meeting their eligibility criteria.  
Pearson and Lipton’s synthesis of these 30 studies indicated that TCs were effective in 
reducing recidivism. Specifically, these authors’ analyses found that six of the seven TC 
studies reviewed produced substantial reductions in recidivism; the overall mean 
weighted r effect size was 0.133 (p = 0.025) with positive effect sizes ranging from .13 to 
.28 [one effect size was negative (-0.16)]. In contrast, the mean effect size was not 
statistically significant for either boot camp or group counseling programs—indicating 
that these programs are no more effective than no treatment. Additionally, Pearson and 
Lipton found that too few studies evaluated other types of interventions to draw strong 
conclusions about their effectiveness. Overall, however, these authors characterized the 
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evidence assessing the effectiveness of methadone maintenance, drug education, 
cognitive-behavioral, and 12-step programs as being promising. 
In many regards, this systematic review is an extension of the work by Pearson 
and Lipton. Like the work of Pearson and Lipton, this synthesis systematically and 
comprehensively reviews the effects of incarceration-based drug interventions on post-
treatment drug use and other types of criminal behaviors using meta-analytic 
procedures. The primary substantive difference between their work and the current 
systematic review is that this research project uses a more current time frame (1980 
through 2004). We believe that this difference is salient for two reasons: (1) more recent 
evaluations of drug treatment interventions may be more generalizable to current 
correctional practices; and, (2) numerous evaluations of incarceration-based drug 
treatment programs have been conducted since 1996. Given this difference in time 
frames, our results may differ somewhat from those of Pearson and Lipton’s work.  
 
2 Objectives of the Review 
 
 The objective of this review was to systematically synthesize the available 
evidence regarding the effectiveness of incarceration-based drug treatment interventions 
in reducing drug relapse and recidivism. More specifically, this systematic review 
focused on addressing the following research questions: Are incarceration-based drug 
treatment programs effective in reducing recidivism and drug use? Approximately how 
effective are these programs (i.e., what’s the magnitude of the effect)? Are there 
particular types of drug treatment programs that are especially effective or ineffective? 
What characteristics differentiate effective programs from ineffective programs? These 
questions are addressed using quantitative meta-analytic synthesis techniques. 
 
3 Methods 
 
3.1  Criteria for inclusion and exclusion of studies in the review 
 
The scope of this review was experimental and quasi-experimental evaluations of 
incarceration-based drug treatment programs for juveniles and adults that utilized a 
comparison group. The eligibility criteria for this review were that: (1) the study evaluated 
an intervention which was administered in a correctional facility (i.e., prison or jail); (2) 
the intervention specifically targeted substance users; (3) the evaluation used an 
experimental or two-group quasi-experimental research design which included a no-
treatment or minimal treatment comparison group; (4) the study reported an outcome 
measure involving post-release criminal behavior (this concept includes drug use); (5) 
the intervention was conducted between 1980 and 2004, inclusive; and, (6) the study 
had to report enough information to calculate an effect size. Note that eligible studies 
could be published or unpublished. 
Regarding the first eligibility criterion, our operational definition of “correctional 
facilities” included only jails and prisons, and analogous facilities for juveniles.  
Interventions conducted at half-way houses or community-based residential facilities 
were not included. It is worth noting that this criterion excluded a small number of 
noteworthy studies. Specifically, programs designed to be alternatives to incarceration 
such as those reported in Dynia and Sung (2001) and Knight and Hiller (1997) were 
excluded by this criterion. 
The second criterion restricted the focus of this review to studies that specifically 
targeted drug users. Therapeutic interventions conducted in correctional facilities that 
were generally available to offenders regardless of an offender’s drug history were not 
included. For instance, Shaw and MacKenzie (1990) evaluated the effects of a boot 
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camp program on a sub-sample of drug using offenders; however, this evaluation was 
excluded because the boot camp program was not specifically targeted at drug users. 
Similarly, Jones, Oslon, Karr, and Urbas (2003 and other years) annually report on the 
effectiveness of a correctional boot camp in Illinois that does not appear to specifically 
target drug users; thus, this study was also excluded. By contrast, Zhang (2000) 
evaluated a boot camp program specifically geared towards drug users—this evaluation 
was included in this review. This criterion was necessary, because this review is 
concerned with incarceration-based drug treatment; without this criterion, the present 
review would become a review of incarcerated-based interventions comprised of drug 
users (and given the large proportion of incarcerated offenders who are drug users, such 
a review runs the risk of becoming a review of nearly all incarceration-based 
interventions).  
The third criterion specified that all included evaluations must have a 
comparison/control group that received no treatment or minimal treatment. Therefore, 
we excluded quasi-experiments that involved comparisons of two or more interventions 
that were roughly comparable or whose comparability in terms of effectiveness in 
reducing recidivism was in dispute (i.e., treatment-treatment comparisons or dose-
response evaluations). For example, the comparison group in Swartz, Lurigio, and 
Slomka (1996) was constructed by dividing program participants into four groups based 
upon length of program participation. Evaluations utilizing such comparison groups were 
not included in this systematic review. Furthermore, we did not include evaluations in 
which the comparison group was comprised predominantly or solely of dropouts from the 
intervention of interest. For instance, evaluations such as Field (1985, 1989) and 
Berggen and Svard (1990), all of which used program drop-outs as the comparison 
group, were excluded from this systematic review. Evaluations that utilized program 
drop-outs as the comparison group were excluded, because extant research clearly 
demonstrates that drug treatment drop-outs and program completers often differ on 
important observed variables (and most likely on important unobserved variables as 
well) prior to the intervention (see e.g., Hiller, Knight, and Simpson, 1999); and thus, 
selection bias is particularly problematic in this research design.  
The fourth and fifth criteria are largely self-explanatory. It is important to 
emphasize, however, all studies needed to report a post-release measure of recidivism. 
This criterion excluded a few notable studies, such as Shewan, Macpherson, Reid, and 
Davies (1996) and Dolan, Shearer, MacDonald, Mattick, Hall, and Wodak (2003), which 
reported in-prison outcomes. 
The last criterion excluded studies that did not report enough information to 
calculate to an effect size. This criterion was necessary for practical purposes. 
Unfortunately, several otherwise eligible studies (e.g., Schippers, Van Den Hurk, 
Breteler, and Meerkerk, 1998; Guerin, 2002) were ruled ineligible based on this last 
criterion. 
 
3.2  Search strategy for identification of relevant studies 
 
The goal of the search strategy was to identify all studies, published or 
unpublished, meeting the above eligibility criteria. In order to achieve this objective, a 
multi-pronged search strategy was utilized. The search began by conducting a 
computerized keyword search of bibliographic databases.  In particular, we conducted a 
search of the following databases: PsychLit, MedLine, NCJRS, Criminal Justice 
Abstracts, Dissertation Abstracts, Sociological Abstracts, Social Science Citation Index, 
SocioFile, Conference Papers Index, UnCover, C2 SPECTR, and CINAHL, as well as 
Google internet searches. The keywords used were: drug treatment, substance abuse 
treatment, drug counseling, therapeutic community(ies), methadone maintenance, boot 
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camp(s), offenders, residential substance abuse treatment (RSAT), RSAT, drunk driver, 
drink driver, DUI, DWI, inmates, incarceration, incarcerated, prison, evaluation, outcome 
evaluation, and recidivism. These keywords were used in various combinations. See 
Appendix 1 for a more detailed discussion of the specific combinations.  
We also searched for eligible studies by carefully reading existing studies and 
literature reviews for unfamiliar studies. In particular, we reviewed the reference lists of 
existing syntheses to identify eligible studies. Likewise, many of the eligible studies 
reviewed the work of similar studies; these studies were also assessed for eligibility. 
Additionally, we reviewed the Digest of Research on Drug Use and HIV/AIDS in Prisons 
(Flanagan, Arsovksa, Giaime, Goril, Kahl, Król, and Moore, 2004), which abstracts much 
of the “grey” literature, particularly European grey research. 
Further, we searched websites of several prominent research organizations. 
Specifically, we searched for relevant research reports on the following websites: 
Correctional Service Canada’s research publications page (http://www.csc-
scc.gc.ca/text/research_e.shtml); the Home Office (http://www.homeoffice.gov.uk/); 
RAND Drug Policy Research Center (http://www.rand.org/multi/dprc/); The Urban 
Institute’s crime /justice research page (http://www.urban.org/justice/index.cfm); and, 
Vera Institute of Justice publications page 
(http://www.vera.org/publications/publications.asp). 
We also hand searched the titles/abstracts of articles published between 1999 to 
2004 in the following journals: Journal of Substance Abuse Treatment, International 
Journal of Offender Therapy and Comparative Criminology, Journal of Drug Issues, The 
Prison Journal, Crime & Delinquency, and Journal of Offender Rehabilitation. We chose 
to hand search these journals because they have a strong track record of publishing 
relevant studies and many of these journals were not indexed well by the computerized 
databases we utilized.  
Finally, our search strategy and its results were reviewed by an information 
specialist. The information specialist supplied a list of additional studies that appeared 
relevant.  
All studies that appeared to be eligible based on a preliminary review of the title 
and abstract were retrieved and closely scrutinized to determine final eligibility status. 
Specifically, we reviewed the title and abstract of each search result for strong evidence 
of ineligibility. That is, we reviewed each title/abstract looking for clear evidence that the 
study violated one or more of the eligibility criteria (see section 3.1). For example, the 
first eligibility criterion is that all studies evaluated an intervention administered in a 
correctional facility; thus, if a title/abstract clearly indicated that the evaluation assessed 
a program that was not administered in a correctional facility, then the study was not 
retrieved for further scrutiny. Those studies that could not be ruled as ineligible based on 
the title/abstract review were retrieved for further assessment of eligibility. Retrieved 
studies were read closely to determine final eligibility status.  
 
3.3 Description of methods used in the component studies 
 
The basic research design for eligible studies was a treatment and comparison 
group design with a post-release outcome measure of interest, such as post-release 
criminal offending or drug use. Studies varied with respect to the method of constructing 
the comparison group; common variations were historical comparisons, adjacent 
jurisdictions, offenders eligible for the treatment program who chose not to participate, 
eligible offenders who did not participate due to limited space in the drug treatment 
program, and random assignment. The studies also varied with respect to the degree to 
which they employed statistical controls (matching, covariate analysis, etc.) to reduce 
the threat of selection bias. Included studies exhibited variation in the type of recidivism 
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measure (e.g., arrests, convictions, re-incarceration) and type of drug use measure (e.g., 
self-report, urinalysis). Our coding forms were designed to capture these methodological 
variations. 
 
3.4  Criteria for determination of independent studies 
 
Several types of statistical dependencies were evident in evaluations of 
incarceration-based drug treatment programs. One common dependency was created 
by multiple measures of criminal behavior (e.g., re-arrest, re-conviction, drug use) or 
multiple follow-up periods for the same indicator of criminal behavior ups (e.g., 6 months, 
12 months). Another common dependency was produced by multiple studies reporting 
findings from the same sample of research participants.   
The statistical methods detailed below required statistical independence of study 
findings. We utilized several strategies to maintain the statistical independence of study 
findings. First, all evaluations (i.e., treatment/comparison contrasts) were cross-checked 
against one another to ensure that multiple studies reporting the results of the same 
evaluation do not contribute multiple estimates of program effects to any analysis.  
Second, in evaluations that report multiple measures of criminal behavior, rather than 
averaging these multiple outcomes, we applied a set of selection criteria that created five 
data sets of effect sizes, with a particular evaluation contributing only one effect size to 
each of the data sets. In the first data set preference was given to effect sizes that: (1) 
were general (i.e., covered all offense types as opposed to being offense specific), (2) 
were based on arrest, (3) were dichotomous, and (4) followed sample members for 12 
months. We preferred effect sizes meeting these criteria, because arrest is more 
proximate to offending than the other outcome measures, and because such effect sizes 
were commonly reported outcome measures. And thus effect sizes meeting these 
criteria provided a comparable measure of program effectiveness across studies. If no 
such effect size was available we selected the effect size that most closely matched 
these criteria. For example, property offenses were more general than violent offenses, 
effect sizes based on re-convictions were preferred over re-incarcerations, and effect 
sizes following sample members closest to 12 months were preferred over other effect 
sizes. Each independent evaluation contributed one, and only one, effect size to this 
“general recidivism” data set. This general recidivism data set served as the main data 
set in the analyses that follow. 
 We also created four more specific data sets: one data set for re-arrest, re-
conviction, re-incarceration, and drug relapse outcomes. In creating these data sets we 
had considerably fewer effect sizes to choose from. When multiple effect sizes were 
available for any of these data sets, preference was given to effect sizes that: (1) were 
general (i.e., covered all offense types as opposed to being offense specific), (2) were 
dichotomous, and (3) followed sample members for 12 months. If a study did not report 
one of these specific types of outcomes, then that study did not contribute to the 
particular data set. For example, if a study reported only an arrest outcome, then this 
study would contribute to the arrest data set but not to the re-conviction, re-incarceration, 
or drug relapse data sets. 
 
3.5  Details of study coding categories 
 
 The coding forms employed in this review are provided in Appendix 2.  These 
coding forms were structured hierarchically, in order to explicitly recognize the nested 
nature of effect sizes within studies. Any number of effect sizes could be coded from 
each evaluation using these forms [see Lipsey and Wilson (2001) for a discussion of this 
issue]. 
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 The coding forms captured key features of the nature of the treatment, research 
participants, research methodology, outcome measures, and direction and magnitude of 
observed effects. Two coders assessed each study. Discrepancies between coders 
were resolved by one of the principal investigators.   
 
3.6  Statistical procedures and conventions 
 
 An effect size was calculated for each evaluation contrast. We utilized the odds-
ratio effect size for dichotomous outcomes as this type of effect size is the most 
appropriate for dichotomous outcome measures (Lipsey and Wilson, 2001).  Indicators 
of criminal behavior based on a continuous scale were coded using the standardized 
mean difference effect size.  These effect sizes were coded in manner such that positive 
effect sizes indicate the treatment group had a more favorable outcome than the 
comparison group (i.e., less recidivism or drug use). The odds-ratio effect size (ESor) is 
defined as:  
 
 /(1 )
/(1 )
c c
or
t t
P PES
P P
−= −  
 
where Pc is the probability of the event (e.g., re-arrest) for the comparison group and Pt 
is the probability of the same event for the treatment group.5 The standardized mean 
difference effect size (ESd) is defined as:  
 
 c t
d
pooled
X XES
S
−=  
where cX is the comparison group mean, tX
tX
is the treatment group mean, and spooled is 
the pooled within groups standard deviation, defined as: 
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where 2ts  is treatment group variance, 
2
cs is the comparison group variance, nt is the 
treatment group sample size, and nc is the comparison group sample size. Odds-ratio 
effect sizes and standardized mean difference effect sizes were combined using the 
method developed by Hasselblad and Hedges (1995). Specifically, mean difference 
effect sizes were transformed onto the odds-ratio effect size scale. 
Our analyses of these effect sizes utilized the statistical approach outlined by 
Lipsey and Wilson (2001) and Wang and Bushman (1999). In particular, we used the 
inverse variance method and assumed that the true treatment effects varied as a 
function of both measured (i.e., coded study features) and unmeasured differences 
between studies. In order to capture unmeasured differences between studies, a random 
effects component was added to the fixed effects weights calculated for each effect, as 
follows:  
 
v* = v+ vθ 
 
                                                 
5 Note that we used the inverse of the odds-ratio, as we were interested in obtaining values 
greater than 1 to reflect a lower probability of recidivism in the treatment group relative to the 
comparison group. 
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where v is the sampling error variance and vθ is the random effects variance estimated 
from the distribution of effect sizes.   
 Our analyses employed Stata macro programs written by D. B. Wilson.6 These 
macro programs calculated the random effects variance component discussed above 
and computed various statistics such as the overall mean effect and the homogeneity of 
effects statistic. Further, we also used these macro programs to determine which study 
features were associated with observed study effects via meta-analytic analogs to 
analysis of variance and regression, assuming a mixed-effects model estimated via 
maximum likelihood (Raudenbush, 1994; Overton, 1998). Our publication bias analyses 
utilized the “metabias” (which performs two tests for publication bias) and the “metatrim” 
(which conducts a statistical correction for publication bias) Stata macro programs 
written by Thomas J. Steichen (both of these macros are available via Stata’s “net 
install” command). Finally, we conducted power analyses utilizing the methods 
described in Hedges and Pigott (2001).  
 
3.7  Treatment of qualitative data 
 
 We did not include qualitative research in this systematic review. However, we 
are open to suggestions from and collaboration with researchers specializing in such 
techniques in future updates of this synthesis. 
 
4 Findings 
 
4.1  Description of Eligible Studies 
 
 Our search strategy uncovered 233 potentially eligible studies. We were able to 
obtain copies of 229 of these studies. Of the retrieved studies, 53 unique studies met our 
eligibility criteria. These 53 unique studies reported the results of 66 independent 
evaluations, as one study may contain multiple evaluations. In particular, nine unique 
studies reported the results of multiple evaluations. Seven of these studies reported the 
results of two evaluations, one study reported the results of three evaluations, and one 
study (Tunis et al., 1995) reported results from five independent evaluations. The 66 
evaluations coded from the 53 unique studies are the unit of analysis for this synthesis. 
The overwhelming majority of the included evaluations were conducted in the 
United States. Fifty-eight of these evaluations were conducted in the United States, 
three evaluations were conducted in Australia, three other evaluations were conducted 
in Canada, one evaluation was conducted in the United Kingdom, and one evaluation 
was conducted in Taiwan. Approximately, half of the evaluations (32) were coded from 
studies published as journal articles or book chapters, and the other 34 evaluations were 
coded from unpublished technical reports and government documents. In regards to 
date of publication, a little over half of the evaluations (34) were coded from studies 
made available after 1999. Interestingly, two-thirds of the evaluations were coded from 
studies made available after 1996—the latest date eligible for inclusion in Pearson and 
Lipton’s (1999) review; thus, the vast majority of the evaluations included in the current 
research were not included in the earlier review.   
 
                                                 
6 As of this writing, David Wilson has made these macro programs available to the public at: 
http://mason.gmu.edu/~dwilsonb/ma.html 
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4.2  Overall Mean Effects Across Studies 
 
Sixty-five of the 66 evaluations reported at least one measure of post-release 
offending (one evaluation reported only drug use outcomes). After applying our effect 
size selection criteria (see section 3.4 for a description of these criteria), approximately 
83% of the 65 general recidivism odds-ratios indicated that the treatment group had less 
recidivism than the comparison group. Examination of the distribution of general 
recidivism odds-ratios suggested that one evaluation was an outlier (0.016)7; instead of 
dropping this effect size from the analyses, we decided to Windorize this effect size to 
the 5th percentile. 
 Table 1 displays the random effects mean odds-ratio for the general recidivism 
measure. The mean odds-ratio for this outcome was 1.37 with the 95 percent confidence 
interval ranging from a lower bound of 1.24 to an upper bound of 1.51, indicating that, on 
average, participation in these drug treatment programs was associated with a reduction 
in post-treatment offending. A more intuitive sense of this effect size can be gained by 
transforming this effect size into a percentage. For heuristic purposes, we assumed a 
35% recidivism rate for the comparison group (which was the unweighted average rate 
of recidivism for all comparison groups), given this assumption the overall mean odds-
ratio translates into a recidivism rate of approximately 28% for the treatment group; thus, 
participation in treatment was associated with a 20% reduction in recidivism (i.e., 
28% 35% 20%
35%
− ≈ − ).8    
The distribution of the general recidivism measure exhibited considerably more 
variability than expected by sampling error alone (Q = 551.84, df = 64, p < 0.001). This 
finding suggested that features of the treatment programs, research methodology, 
and/or characteristics of the sample may moderate the size of the observed treatment 
effect. Analyses in the subsequent sections tested this possibility.  
 Table 1 also displays random mean odds-ratios for the four outcome specific 
data sets (see section 3.4 for a description of these data sets). From this table it is 
apparent that evaluations utilizing re-convictions as the outcome measure exhibited the 
largest mean odds-ratio, whereas evaluations utilizing re-incarceration measures of 
recidivism had the smallest mean odds-ratio. We believe that our general recidivism 
outcome measure is the best available, as it is the indicator of criminal behavior least 
likely to be differentially affected by criminal justice system actors based on the study 
condition of the offender. Furthermore, it is the most comparable indicator of program 
effectiveness across studies, and, thus, we utilized this measure in the analyses 
reported in section 4.2 (below).  
 Interestingly, only 20 of the 66 independent evaluations assessed the effect of 
drug treatment on post-release drug use (see Figure 3). The random effects mean odds-
ratio for these 20 independent evaluations was 1.28 (with a 95% confidence interval of 
0.92 to 1.78). Thus, this mean odds-ratio was not statistically significant; this non-
significant finding was not due to a lack of statistical power, as our post-hoc power 
analyses indicated that the power of this analysis to detect a small effect (i.e., a logged 
odds-ratio of 0.20) was 0.99.9 Additionally, the distribution of effect sizes exhibited more 
                                                 
7 This odds-ratio converts into a logged odds-ratio of -4.61; no other log odds-ratio had an 
absolute value of 2 or more. This odds-ratio came from an evaluation of a narcotics maintenance 
program (Magura et al., 1993—female sample).  
8 If we assumed a 50% rate of recidivism for the comparison group, then this effect size translates 
into a 42% recidivism rate for the treatment group, a 16% reduction in recidivism. 
9 All power analyses were conducted using a two-tailed significance level of 0.05. All power 
analyses utilized observed data (i.e., standard errors, number of studies, etc.); thus, these power 
analyses were post-hoc.  
Incarceration-based drug treatment   13 
variability than expected by sampling error alone (Q = 197.97, df = 19, p < 0.001), which 
again suggested that moderator variables may explain some of the variability in the drug 
relapse odds-ratios.  
 
4.3 Analysis of Moderator Effects 
 
The above analyses indicated that the effect size distributions displayed more 
variability than expected by chance alone. This finding suggested that there may be 
important differences in research methodology, sample, and/or interventions that may 
account for some effect size variability. We tried to capture important differences 
between studies by coding information from each of the included studies; however, our 
ability to code many relevant study features was limited by the quality of the descriptions 
provided by the primary authors. 
The first moderator variable examined was primary type of intervention. As noted 
above (see section 1) the coded evaluations involved four types of primary treatment 
interventions: TCs, counseling programs, boot camps, and narcotic maintenance 
programs. The majority of the evaluations concerned TCs (30). Another sizeable portion 
of evaluations (25) assessed counseling programs. Only a handful of evaluations 
assessed boot camps or narcotic maintenance programs, 2 and 6, respectively. And 
three evaluations were not described in enough detail to allow categorization.  
Table 2 reveals the mean general recidivism odds-ratio varied considerably by 
type of primary intervention (Q = 6.36, df = 3, p = 0.09). On average, TC and counseling 
interventions exhibited statistically significant reductions in general recidivism. In 
particular, evaluations of TC programs had a mean odds-ratio of 1.38 (with a 95% 
confidence interval of 1.17 to 1.62), which translates into a 28% recidivism rate for 
participants in these programs, if we continue to assume a 35% recidivism rate for the 
comparison group. Evaluations of counseling programs had a mean odds-ratio of 1.50 
(with a 95% confidence interval of 1.25 to 1.79). This means odds-ratio translates into a 
26% recidivism rate for counseling participants, assuming a 35% recidivism rate for the 
comparison group.  
On the other hand, the mean odds-ratios for both boot camps and narcotic 
maintenance programs were not statistically different from 1 indicating that participation 
in these programs generally was not associated with statistically significant reductions in 
recidivism. More specifically, two evaluations of boot camp programs for drug offenders 
were included in the present research. Both of these evaluations yielded small, positive 
logged odds-ratios (0.06 and 0.14); neither of these logged odds-ratios were statistically 
significant. The fixed effects mean odds-ratio for the two boot camp evaluations was 
1.10 (with a 95% confidence interval of 0.61 to 1.97). The finding regarding boot camps’ 
lack of effectiveness is not due to a lack of statistical power. In fact, post-hoc power 
analysis indicated that the power of this analysis to detect a small effect (i.e., a logged 
odds-ratio of 0.20) was 0.93, which exceeds the standard benchmark of 0.80. Somewhat 
similarly, five odds-ratios were extracted from evaluations of narcotic maintenance 
programs. Four of the five logged odds-ratios were negative. The random effects mean 
odds-ratio for narcotic maintenance evaluations was 0.84 (with a 95% confidence 
interval of 0.54 to 1.30). The statistical power of this analysis to detect a small effect was 
very low; thus, the small number of boot camp evaluations did not limit statistical power, 
but the small number of incarceration-based narcotic maintenance programs did limit 
statistical power. As a result, little can be said about the potential of incarceration-based 
narcotic maintenance programs beyond that the limited existing evidence is 
discouraging.  
Preliminary moderator analyses indicated that the association between odds-
ratio and several moderator variables depended on whether the odds-ratio came from an 
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evaluation of a TC or counseling program. Therefore, we conducted separate moderator 
analyses for TCs and counseling programs, in a series of parallel analyses. The odds-
ratios concerning boot camp and narcotic maintenance programs were set aside for 
these analyses. 
It is important to note that the moderator analyses presented in Tables 3 through 
11 have limited statistical power. The statistical power to detect a small effect for these 
moderator analyses ranged from approximately 0.10 to 0.40.10 The limited statistical 
power of these analyses means that only contrasts with large effects were likely to be 
statistically significant; stated differently, many substantively meaningful effects were not 
statistically significant at conventional levels of significance (i.e., p < 0.05), as a result of 
these analyses low statistical power. To combat the low statistical power of these 
analyses, we employ two strategies. First, we interpret as statistically significant any 
contrast that has a probability of occurring by chance alone of less than 10% (i.e., p < 
0.10). Second, instead of relying solely on statistical significance, in the following 
moderator analyses we also discussed substantively significant effects; that is, effects 
that appear to be substantively large, even if not statistically significant, were treated as 
noteworthy. We defined “substantively significant” relationships based on the magnitude 
of the difference between categories in terms of the logged odds-ratio. Specifically, if a 
moderator variable’s categories differed by a logged odds-ratio of 0.20 or more and each 
category had a least five evaluations, then we considered such differences as 
substantively significant. Similarly, if one category of a moderator had less than five 
evaluations and the difference between categories was 0.40 or more, then we 
considered such differences as substantively significant.   
Another limitation of the moderator analyses presented in Tables 3 through 11 is 
that all of these analyses were bivariate. Unfortunately, the sparseness of the data sets 
utilized made multivariate data analysis highly problematic and the results of such 
analyses were very sensitive to small alternations (e.g., deleting one observation). As a 
result, these bivariate findings are vulnerable to spuriousness; consequently, the results 
of the moderator analyses should be viewed as suggestive.  
Tables 3, 4, and 5 display the results of series of bivariate moderator analyses 
using odds-ratios from TCs only. Table 3 examines variation in the general recidivism 
odds-ratios by coded methodological features. The first moderator variable, “overall 
method quality,” was a four-point ordinal measure of the internal validity of each 
evaluation. This four-point categorization was similar to the University of Maryland’s 
Scientific Methods Scale (see Farrington et al., 2002). The lowest level of method quality 
was weak quasi-experimental designs; these studies utilized a comparison that lacks 
comparability to the treatment group before the intervention. The next level of method 
quality, “standard quasi-experiment,” was assigned to evaluations characterized by 
research designs that used a comparison group that was slightly different from the 
treatment group on important observed variables before the intervention. “Rigorous 
quasi-experiments” were characterized as evaluations involving treatment and 
comparison groups that were highly comparable on important observed variables (e.g., 
age, gender, prior criminal history, prior drug use), or evaluations that employed slightly 
different treatment and comparison groups but also used multivariate analyses that 
controlled for pre-existing differences on important variables. The highest level of 
                                                 
10 If we increase the significance level to 0.10, the statistical power to detect a small effect for 
these moderator analyses ranges from approximately 0.20 to 0.50. This level of statistical power 
is still well below the standard of 0.80. And thus, statistical power is still limited even if the 0.10 
level of significance is utilized.  
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method quality, “experimental designs,” randomly assigned research participants to 
conditions and did not have attrition problems (see the coding forms in Appendix 2).11   
Based on this variable, most of the included evaluations were methodologically 
weak. Of the 30 TC evaluations, 11 (37%) were rated as rigorous quasi-experiments or 
experimental designs. The modal method ranking was “standard quasi-experiment”; 13 
of the 30 evaluations earned this ranking. It is important to note that the mean odds-
ratios for the three highest levels of method quality were statistically significant—
indicating that the effectiveness of TCs was not confined to only methodologically weak 
evaluations.  
The mean odds-ratio for each level of method quality exhibited a weak positive 
trend. That is, evaluations with the lowest method quality rating had the smallest odds-
ratios and evaluations with the highest method quality had higher odds-ratios. The meta-
analytic analog to analysis of variance indicated that the variation between levels of 
quality method was statistically significant (p = 0.099). This finding suggests that more 
methodologically rigorous evaluations found stronger evidence of treatment 
effectiveness.  
Table 3 also indicates that few of the coded methodological features were 
associated with treatment effectiveness among the evaluations of TC programs. 
Methodological factors such as random assignment, subject-level matching, and the use 
of multivariate analyses to control for pre-existing differences between treatment and 
comparison groups all were not associated with effect size. Additionally, Table 3 reveals 
that nearly all of the mean odds-ratios were statistically significant, which suggests that 
the finding of the effectiveness of TCs was robust to methodological variations. 
The moderator analysis found that published studies exhibited statistically larger 
effect sizes than unpublished studies. This finding is an indication of publication bias in 
evaluations of TC programs. As a further test for the presence of publication bias in 
these evaluations, we conducted statistical tests for publication bias. Specifically, we 
conducted both the Begg and Mazumdar (1994), and the Egger, Smith, Schneider, and 
Minder (1997) tests for publication bias. The more statistically powerful Egger et al. 
method found evidence of publication bias; that is, the test of the null hypothesis that the 
intercept for the regression of the standardized effect estimates against their precision 
equals zero was rejected (p = 0.001). Given this finding, we conducted Duval and 
Tweedie’s (1997) “trim and fill” method for accounting for publication bias. This 
procedure added seven effect sizes to the distribution, which in turn lowered the mean 
random effects odds-ratio to 1.21 with a 95% confidence interval of 1.08 to 1.36 (Q = 
252.90, df = 36, p < 0.001); this publication bias adjusted mean odds-ratio translates into 
a recidivism rate of approximately 31% for the treatment group, if we continue to assume 
a 35% recidivism rate for the comparison group.  
Table 4 presents the results of a similar bivariate analysis between the general 
recidivism odds-ratios and sample characteristics. Four sample characteristics were 
consistently reported by evaluators: age group (juvenile or adult), gender composition of 
sample, racial composition of sample, and type of offenders (violent/non-violent 
offenders). Our analyses found that none of the sample characteristics displayed a 
statistically or substantively significant relationship with effect size. Once again, 
however, it is important to note that nearly all of the mean odds-ratios in Table 4 were 
statistically significant and at least modestly large, which suggests that TC programs 
were effective with many different types of samples. 
                                                 
11 We coded two types of attrition problems: total and differential. Total attrition problems were 
defined as overall attrition of 20% or greater, or if the primary authors indicated that attriters 
differed substantially from non-attriters. Differential attrition problems were defined similarly; that 
is, differential attrition of 20% or greater, or if the primary authors indicated that attrition 
substantially reduced the comparability of the treatment and comparison group. 
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Characteristics of each intervention were also coded. Bivariate analyses 
analyzing these characteristics as moderator variables are shown in Table 5. Six 
treatment characteristics were coded: mandatory aftercare, location of intervention (i.e., 
jail vs. prison), length of treatment, program maturity, nature of participation (i.e., strictly 
voluntary vs. at least some non-voluntary participation), and program capacity/average 
number of participants (not shown in Table 5). Once again, none of the coded 
characteristics were statistically or substantively related with effect size, and evidence of 
the effectiveness of TCs was largely robust to coded variation in treatment features. 
Specifically, although evaluations of TC programs that mandated aftercare treatment, or 
programs that required all participants to volunteer for treatment produced somewhat 
larger effect sizes than other programs, these features were not related to magnitude of 
effect size. Similarly, programs with short treatment durations were somewhat less 
effective than longer programs, but this difference also was not significant. In fact, these 
evaluations found evidence of the effectiveness of TC programs regardless of these 
coded differences in treatment characteristics. Thus, once more the evidence suggests 
that participants in TC programs had lower recidivism rates than non-participants, 
regardless of several prominent evaluation characteristics.  
A parallel set of analyses were conducted for counseling programs (see Tables 
6, 7, and 8). Again, most evaluations were methodologically weak. Over two-thirds of 
evaluations (72%) were rated as either “weak” or “standard” quasi-experiments. Only 
two evaluations employed an experimental design that randomly assigned offenders to 
treatment conditions. This lack of methodological rigor is particularly problematic as 
evaluations rated higher on this scale exhibited smaller non-statistically significant mean 
odds-ratios than evaluations rated lower on the scale. In particular, evaluations rated as 
“rigorous” quasi-experiments or “experimental designs” exhibited mean effect sizes of 
1.33 (with a 95% confidence interval of 0.86 to 2.06) and 1.09 (with a 95% confidence 
interval of 0.52 to 2.30), respectively; neither of which were statistically significant. While 
the statistical test comparing the mean odds-ratios for the various levels of 
methodological rigor was not statistically significant, this finding suggests that the 
strongest evidence of the effectiveness of counseling programs in reducing re-offending 
came from methodologically weak evaluations.  
The only methodological variables that had a statistically significant association 
with magnitude of odds-ratio were differential attrition and multivariate data analysis (see 
Table 6). In particular, evaluations that employed multivariate data analysis yielded 
larger effect sizes than evaluations that did not utilize such techniques. And evaluations 
in which differential attrition was apparent had statistically smaller odds-ratios than 
evaluations without substantial differential attrition. Further, while not statistically 
significant, evaluations without considerable overall attrition had substantively larger 
mean effect sizes than other evaluations. It is also worth noting that the moderator 
distinguishing published from unpublished studies found no difference in the magnitude 
of the effect for counseling programs (see Table 6). This finding comports with other 
tests of publication bias (not reported in the tables); that is, both the Begg and 
Mazumdar, and Egger et al. tests for publication bias retained their null hypotheses (no 
publication bias).  
Two of the four moderator variables capturing sample differences were 
statistically related to effect size (Table 7). Evaluations with adult samples had a 
statistically larger mean odds-ratio than evaluations using juvenile samples. Likewise, 
evaluations that employed female samples exhibited statistically larger mean odds-ratio 
than either male samples, or mixed gender samples; in fact, post hoc contrasts indicated 
that all three mean odds-ratios statistically differed from one another. Racial composition 
of sample had no substantive or statistical relationship to effect size. In fact, counseling 
programs were effective in reducing re-offending in all of the racial categories. 
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In regards to treatment characteristics, mature counseling programs and 
voluntary programs exhibited statistically larger effect sizes than other evaluations (see 
Table 8). None of the other coded treatment characteristics had a substantive or 
statistical relationship with effect size. In concordance to the analyses of TC evaluations, 
programs with a mandatory aftercare component had a larger mean effect size than 
programs without aftercare, but the difference was not significant. Once again, it is 
important to note that the moderator variable analysis had low statistical power, so this 
finding (and other non-significant findings) may be due to a lack of power. 
Lastly, we examined the moderator variables’ ability to predict variation in drug 
relapse odds-ratios (see Tables 9, 10, and 11). Because of the limited number of effect 
sizes involved in these analyses (19), we were unable to conduct separate analyses for 
the different types of primary treatment; therefore, in these analyses all types of primary 
treatment were analyzed together. 
Perhaps the most striking revelation from the moderator analyses of drug relapse 
outcomes is that few of the mean effect sizes were statistically significant. This finding 
suggests that, with few exceptions, regardless of variations in methodology, sample, or 
treatment characteristics incarceration-based drug treatment does not generally reduce 
post-release drug use. Only evaluations with the following characteristics exhibited odds-
ratios statistically greater than 1 (indicating a significant reduction in drug use): use of 
random assignment or lack of subject-level matching, samples comprised of adults or 
females, and programs that were voluntary, had mandatory aftercare, or were based on 
the TC model. Further, only the methodological quality, age group of sample, and 
presence of aftercare moderator variables were statistically significant; whereas, the 
subject-level matching, gender composition, type of treatment, and voluntary 
participation moderator variables were all substantively significant. Last, it is important to 
note that while published evaluations exhibited somewhat larger effect sizes than 
unpublished evaluations, statistical tests for publication bias did not indicate the 
presence of publication bias in these evaluations. 
 
5  Conclusions 
 
 Overall, this meta-analytic synthesis of evaluations of incarceration-based drug 
treatment programs found that such programs are modestly effective in reducing 
recidivism. Eight-three percent of the general recidivism odds-ratios favored the 
treatment group over the comparison group. Moreover, the random effects mean odds-
ratio was 1.37, which translates into a 28% recidivism rate for the treatment group, if we 
assume a 35% rate of recidivism for the comparison group. Yet, the effectiveness of 
treatments programs clearly varied by type of treatment.  
In concordance with existing reviews (e.g., Wilson, MacKenzie, and Mitchell, 
2005; Pearson and Lipton, 1999), we found no evidence that participation in boot camp 
programs reduced recidivism or drug use. While the number of independent evaluations 
of boot camp programs for drug offenders was small, given the consistency of our 
findings to other research on boot camps, it appears unlike that boot camp programs 
generally reduce recidivism.  
Similarly, we found limited evidence of the effectiveness of incarceration-based 
narcotic maintenance programs in reducing either re-offending or drug use. The scant 
available evidence suggests that narcotic maintenance programs do not reduce re-
offending; in fact, program participants had somewhat higher re-offending rates than 
non-participants in four out of the five available evaluations. By contrast, all existing 
evaluations found somewhat lower rates of post-release drug use among participants 
than non-participants. Thus, incarceration-based narcotic maintenance programs may 
reduce drug use, but not re-offending. The limited statistical power of the analyses, 
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however, undermines our ability to draw firm conclusions in this area of research. 
Continued research investigating the effectiveness of these programs would be a 
significant contribution to the knowledge base. 
 The most consistent evidence of treatment effectiveness came from evaluations 
of TC programs. These programs consistently showed post-release reductions in re-
offending and drug use. This finding was robust to methodological variation. In fact, even 
among the most rigorous evaluations, participation in TC programs was consistently 
related to reductions in re-offending. We also found that TCs were effective in several 
different types of samples (e.g., female only samples, male only samples, and adult 
samples), which suggests that TCs can be applied to wide-range of offenders. While 
TCs in general were clearly effective, TCs that combined incarceration-based treatment 
with mandatory post-release aftercare exhibited enhanced effectiveness in reducing re-
offending. However, the possibility of publication bias in the available body of TC 
evaluations tempers our findings. That is, there was evidence of publication bias in this 
area of research that apparently over-estimated the effectiveness of TC programs.  
 The evidence regarding counseling programs indicated that these programs were 
effective in reducing re-offending but not drug use. Counseling programs appeared to be 
most effective in reducing re-offending when targeted towards adult or female offenders. 
The evidence also indicated that counseling programs that were strictly voluntary 
appeared to be more effective in reducing re-offending than other counseling programs. 
However, the strongest evidence of the effectiveness of counseling programs came from 
evaluations that were methodological weak. Further, while only a few evaluations of 
counseling programs assessed their effects on drug use, these existing studies did not 
generally find that participation in counseling programs reduced drug use.   
  Interestingly, all of the moderator analyses indicated that treatment programs 
that mandated aftercare after release from incarceration produced larger effect sizes 
than programs that do not. In all but the analyses of drug use effect sizes, these 
differences were not significant. However, given these analyses lack of statistical power, 
sensitivity to the deletion or inclusion of a single evaluation, and the existing evidence 
that finds aftercare to strengthen the effectiveness of such interventions, we believe the 
inclusion of a mandatory aftercare component most likely does intensify the 
effectiveness of incarceration-based drug treatment programs.  
The implications of this research for policy-makers are clear. Policymakers 
seeking effective interventions for incarcerated substance abusers are most likely to find 
success with programs that intensively focus on the multiple problems of substance 
abusers, such as TC programs. Policymakers should expect smaller treatment benefits 
from less intensive treatment programs. Further, based on the existing literature there is 
no evidence that correctional boot camps targeted at substance abusers reduce either 
post-release offending or drug use; and thus, policy-makers should not expect such 
programs to reduce recidivism.  
We believe that this research also has implications for researchers. Specifically, 
we believe that while the extant research clearly supports the effectiveness of certain 
programs, there is a lack of understanding concerning  which particular components of 
treatment programs are most important, and which combination of components are most 
effective. Further, the general methodological weakness of this area of research leaves 
findings vulnerable to alternative explanations (i.e., reductions in recidivism could be due 
to factors other than the intervention). Beneficial future research should address these 
issues. 
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6 Plans for Updating the Review 
 
 We plan to update this systematic review every three years in accordance with 
Campbell Collaboration guidelines. 
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11 Tables 
 
Table 1. Mean random effects odds-ratio by type of recidivism measure 
  95% Confidence Interval    
Outcome Mean ES Lower Upper Q ka 
General recidivism 1.37* 1.24 1.51 551.84* 65 
Re-arrests 1.40* 1.25 1.56 196.52* 35 
Re-convictions 1.43* 1.27 1.61 23.40 17 
Re-incarcerations 1.22* 1.07 1.39 307.59* 35 
Drug relapse 1.28 0.92 1.78 197.97* 20 
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
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Table 2. General Recidivism Odds-Ratio by Treatment Characteristics 
  95% Confidence Interval  
Type of Program Mean ES Lower Upper ka
Therapeutic Community 1.38* 1.17 1.62 30
Counseling 1.50* 1.25 1.79 25
Narcotic Maintenance 0.84 0.54 1.30 5
Boot Camp 1.10 0.61 1.97 2
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
Between Q = 6.36, df = 3, p = 0.09 
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Table 3. General Recidivism Odds-Ratio by Method Variables: TCs Only 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka 
Overall method quality+     
  Weak quasi-experiment 1.03 0.79 1.35 6 
  Standard Quasi-experiment 1.40* 1.17 1.69 13 
  Rigorous quasi-experiment 1.39* 1.09 1.77 9 
  Experimental design 1.90* 1.22 2.97 2 
Randomly assigned to conditions     
  No 1.32* 1.15 1.52 28 
  Yes 1.90* 1.16 3.11 2 
Used subject-level matching     
  No 1.43* 1.23 1.66 24 
  Yes 1.10 0.81 1.50 6 
Used multivariate data analysis     
  No 1.27* 1.04 1.55 14 
  Yes 1.46* 1.20 1.78 16 
Overall attrition apparent     
  No 1.31* 1.12 1.54 23 
  Yes 1.48* 1.01 2.16 5 
Differential attrition apparent     
  No 1.37* 1.17 1.61 23 
  Yes 1.31 0.85 2.01 4 
Published†     
  No 1.16# 1.00 1.36 18 
  Yes 1.69* 1.39 2.05 12 
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10.
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Table 4. General Recidivism Odds-Ratio by Sample Characteristics: TCs Only 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka
Age group of sample     
  Adults 1.37* 1.18 1.60 27
  Juveniles 1.47 0.89 2.43 2
Gender composition of sample         
  All female 1.65* 1.14 2.39 6
  Mixed (male and female) 1.23 0.84 1.79 4
  All male 1.36* 1.13 1.64 18
Racial composition of sample         
  50% or less non-white 1.72* 1.24 2.38 7
  51%-70% non-white 1.35* 1.03 1.78 10
  More than 70% non-white 1.25 0.93 1.68 7
Offender type     
  Non-violent offenders 1.49* 1.24 1.79 15
  Mixed (violent and non-violent) 1.28* 1.02 1.62 9
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 5. General Recidivism Odds-Ratio by Treatment Characteristics: TCs Only 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka
Mandatory aftercare     
  No 1.31* 1.07 1.59 14
  Yes 1.51* 1.16 1.95 9
Treatment location     
  Prison 1.35* 1.16 1.56 27
  Jail 1.56# 0.94 2.60 3
Program maturity     
  New program (less than 1 year) 1.34* 1.10 1.64 14
  Developing program (1-3 years) 1.18 0.79 1.77 4
  Established program (3+ years) 1.45* 1.15 1.83 11
Short treatment (less than 90 days)     
  No 1.45* 1.26 1.68 22
  Yes 1.15 0.79 1.67 3
Strictly voluntary treatment      
  No 1.32* 1.08 1.61 8
  Yes 1.57* 1.35 1.84 16
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 6. General Recidivism Odds-Ratio by Method Characteristics: Counseling 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka
Overall method quality     
  Weak quasi-experiment 1.82* 1.24 2.66 8
  Standard Quasi-experiment 1.49* 1.08 2.06 10
  Rigorous quasi-experiment 1.33 0.86 2.06 5
  Experimental design 1.09 0.52 2.30 2
Randomly assigned to conditions     
  No 1.55* 1.25 1.92 23
  Yes 1.09 0.51 2.32 2
Used subject-level matching     
  No 1.48* 1.15 1.89 19
  Yes 1.59# 0.97 2.61 5
Used multivariate data analysis+     
  No 1.18 0.85 1.63 9
  Yes 1.73* 1.35 2.22 16
Overall attrition apparent      
  No 1.63* 1.28 2.07 18
  Yes 1.15 0.77 1.72 6
Differential attrition apparent†     
  No 1.68* 1.37 2.05 20
  Yes 0.71 0.43 1.16 3
Published     
  No 1.53* 1.07 2.18 9
  Yes 1.49* 1.15 1.94 16
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 7. General Recidivism Odds-Ratio by Sample Characteristics: Counseling 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka 
Age group of sample†     
  Adults 1.53* 1.41 1.67 19 
  Juveniles 1.16 0.92 1.46 3 
Gender composition of sample†     
  All female 2.94* 1.74 4.97 3 
  Mixed (male and female) 1.01 0.69 1.48 6 
  All male 1.67* 1.26 2.21 11 
Racial composition of sample     
  50% or less non-white 1.48* 1.19 1.85 5 
  51%-70% non-white 1.44* 1.21 1.71 6 
  More than 70% non-white 1.50* 1.34 1.68 2 
Offender type     
  Non-violent offenders 1.48* 1.18 1.86 11 
  Mixed (violent and non-violent) 1.26# 0.98 1.62 12 
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 8. General Recidivism Odds-Ratio by Treatment Characteristics: Counseling 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka 
Mandatory aftercare     
  No 1.45* 1.14 1.85 20 
  Yes 1.82* 1.10 3.03 4 
Treatment location     
  Prison 1.56* 1.20 2.04 16 
  Jail 1.42# 1.00 2.01 9 
Program maturity†     
  New program (less than 1 year) 1.08 0.82 1.41 8 
  Developing program (1-3 years) 1.43 0.70 2.92 2 
  Established program (3+ years) 1.79* 1.36 2.37 9 
Short treatment (less than 90 days)     
  No 1.44# 0.98 2.12 10 
  Yes 1.58* 1.12 2.23 11 
Strictly voluntary treatment+     
  No 1.07 0.60 1.92 4 
  Yes 1.75* 1.26 2.44 14 
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 9. Drug Relapse Odds-Ratio by Method Variables 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka
Overall method quality†     
  Weak quasi-experiment 0.70 0.40 1.23 5
  Standard Quasi-experiment 1.46 0.81 2.64 5
  Rigorous quasi-experiment 1.30 0.84 1.99 8
  Experimental design 4.49* 1.37 14.79 1
Randomly assigned to conditions     
  No 1.18 0.83 1.68 18
  Yes 2.51# 0.91 6.93 2
Used subject-level matching     
  No 1.40# 0.95 2.05 16
  Yes 0.93 0.43 2.00 4
Used multivariate data analysis     
  No 1.14 0.68 1.90 9
  Yes 1.43 0.90 2.29 11
Overall attrition apparent     
  No 1.31 0.78 2.20 9
  Yes 1.18 0.72 1.93 10
Differential attrition apparent     
  No 1.33 0.84 2.10 11
  Yes 1.12 0.64 1.96 8
Published         
  No 1.16 0.71 1.88 10
  Yes 1.45 0.88 2.39 10
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 10. Drug Relapse Odds-Ratio by Sample Characteristics 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka 
Age group of sample†     
  Adults 1.58* 1.20 2.08 15 
  Juveniles 0.79 0.45 1.38 3 
Gender composition of sample     
  All female 2.06# 0.97 4.38 5 
  Mixed (male and female) 0.81 0.29 2.26 2 
  All male 1.18 0.77 1.82 12 
Racial composition of sample     
  50% or less non-white 1.86 0.69 5.03 2 
  51%-70% non-white 1.37 0.77 2.44 6 
  More than 70% non-white 1.34 0.76 2.35 6 
Offender type         
  Non-violent offenders 1.41 0.80 2.49 8 
  Mixed (violent and non-violent) 0.94 0.57 1.55 8 
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10. 
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Table 11. Drug Relapse Odds-Ratio by Treatment Characteristics 
  95% Confidence Interval   
Variable Mean ES Lower Upper ka 
Type of program     
  Therapeutic community 1.41# 0.95 2.09 12 
  Boot camp 0.56 0.15 2.06 1 
  Counseling 0.78 0.35 1.73 3 
  Narcotic maintenance 1.95 0.87 4.40 4 
Mandatory aftercare†     
  No 0.75 0.42 1.34 6 
  Yes 1.79* 1.14 2.81 11 
Treatment location     
  Prison 1.25 0.87 1.80 18 
  Jail 1.97 0.52 7.49 2 
Program maturity     
  New program (less than 1 year) 1.01 0.56 1.82 7 
  Developing program (1-3 years) 1.69 0.78 3.67 5 
  Established program (3+ years) 1.26 0.61 2.60 5 
Short treatment (less than 90 days)     
  No 1.10 0.71 1.69 13 
  Yes 2.04 0.85 4.93 4 
Strictly voluntary treatment      
  No 0.93 0.44 1.95 4 
  Yes 1.58* 1.01 2.48 13 
a Number of odds-ratios 
* p < 0.05 
# p < 0.10 
† Difference between means is statistically significant at p < 0.05. 
+ Difference between means is statistically significant at p < 0.10.
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12  Figures 
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Figure 1. General Recidivism Odds-Ratio and 95% Confidence Interval: TCs 
 Favors Comparison  Favors Treatment Author and Year  N
 VAN STELLE & MOBERG 2001  96
 PRENDERGAST ET AL 1996  64
 PRENDERGAST ET AL 2003  180
 HARTMANN ET AL 1997  244
 PEALER ET AL 2002  788
 TUNIS ET AL 1995-JET  150
 MOSHER & PHILLIPS 2001  558
 WEXLER ET AL 1990-MALES  594
 INCIARDI ET AL-EVALS OF CREST  359
 WEXLER ET AL 1999  715
 TAXMAN & SPINNER 1996  528
 WINESBURG ET AL 2002  399
 KNIGHT ET AL-EVALS OF TX ITC  396
 WEXLER ET AL 1990-FEMALES  285
 WELSH 2002  551
 EISENBERG & FABELO 1996  1067
 EISENBERG ET AL 2001  24017
 PELISSIER ET AL 2000-MALES  1842
 NASH 2000  807
 PELISSIER ET AL 2000-FEMALES  473
 MILLER & KOONS-WITT 2003  280
 TUNIS ET AL 1995-SAID  374
 EISENBERG ET AL 2001  24017
 KLEBE & O'KEEFE 2004  778
 GORDON 2002  818
 GRANSKY & JONES 1997  415
 ANGLIN ET AL 2002  801
 GRANSKY & JONES 1997  8399
 PORTER 2002  513
 SIEGAL ET AL 1997  726
 Overall Mean Odds-Ratio
 .1  .25  .50  .75  1  2  5  10  25
 Odds-Ratio
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Figure 2. General Recidivism Odds-Ratio and 95% Confidence Interval: Counseling 
 Favors Comparison  Favors Treatment Author and Year  N
 VOAS & TIPPETTS 1990  2340
 TURLEY ET AL 2004  70
 TURLEY ET AL 2004  67
 CRUNDALL & DEACON 1997  58
 TUNIS ET AL 1995-DEUCE  264
 TUNIS ET AL 1995-REACH  159
 TURLEY ET AL 2004  137
 FINIGAN ET AL 2003-FEMALES  196
 DALEY ET AL 2004  831
 HANSON 2000  271
 MARTIN ET AL 2003  1205
 PORPORINO ET AL 2002  1572
 KUNITZ ET AL 2002  6571
 SMITH 1996  495
 HUGHEY & KLEMKE 1996  394
 WA STATE DOC 1998  676
 FINIGAN ET AL 2003-MALES  190
 KELLY 2001  527
 AOS 2004  273
 PETERS ET AL 1993  420
 LITTLE & ROBINSON 1990  180
 TUNIS ET AL 1995-NEW BEGIN  166
 SEALOCK ET AL 1997  520
 DUGAN & EVERETT 1998  117
 VAUGHN ET AL 2003  628
 Overall Mean Odds-Ratio
 .1  .25  .50  .75  1  2  5  10  25
 Odds-Ratio
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Figure 3. Drug Relapse Odds-Ratio and 95% Confidence Interval 
 Favors Comparison  Favors Treatment Author and Year  N
 INCIARDI ET AL (EVALS OF CREST)  367
 CRUNDALL & DEACON 1997  58
 PRENDERGAST ET AL 2003  180
 HUME AND GORTA 1988  175
 MAGURA ET AL 1993 (FEMALES)  100
 KNIGHT ET AL (EVALS OF TX ITC)  297
 SEALOCK ET AL 1997  392
 MAGURA ET AL 1993 (MALES)  149
 PELISSIER ET AL 2000 (MALES)  1842
 PELISSIER ET AL 2000 (FEMALES)  473
 KINLOCK ET AL 2005  81
 HARTMANN ET AL 1997  244
 WELSH 2002  608
 ANGLIN ET AL 2002  596
 VAN STELLE & MOBERG 2001  96
 PRENDERGAST ET AL 1996  64
 MILLER ET AL 2003  280
 ZHANG 2000 ('97 COHORT)  200
 GORDON 2002  818
 VAUGHN ET AL 2003  208
 Overall Mean Odds-Ratio
 .1  .25  .50  .75  1  2  5  10  25
 Odds-Ratio
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13 Appendix 1: Search Terms  
 
The search strategy for this review began by conducting a computerized keyword 
search of bibliographic databases. In particular, we conducted a search of the following 
databases: PsychLit, MedLine, NCJRS, Criminal Justice Abstracts, Dissertation 
Abstracts, Sociological Abstracts, Social Science Citation Index, SocioFile, Conference 
Papers Index, UnCover, C2 SPECTR, and CINAHL, as well as Google internet 
searches. We split our keywords into three groups: primary terms, secondary terms, and 
independent terms. The primary terms were too broad to be used independently; thus, 
we combined each primary term with each secondary term. We augmented this search 
strategy by utilizing a few independent search terms. The table below lists the primary, 
secondary, and independent search terms. 
Terms used in computerized database search 
Primary Terms Secondary Terms Independent Terms 
Drug treatment Offenders Boot camps 
Substance abuse treatment Inmates Residential substance abuse 
treatment  
Drug counseling Incarceration RSAT 
Substance abuse 
counseling 
Incarcerated  
Methadone maintenance Prison  
Therapeutic 
community(ities) 
Evaluation  
Drunk driver Outcome evaluation  
Drink driver Recidivism  
DUI Arrest  
DWI   
 
For example, the first primary term, “drug treatment,” was combined with each of the 
secondary terms to eliminate extraneous results. Then the second primary term, 
“substance term treatment,” was combined with each of the secondary terms. This 
process was repeated for each primary term. Lastly, we used the independent terms by 
themselves in each database.  
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14 Appendix 2: Coding Forms 
 
Crime Prevention Meta-Analysis 
Study Level Code Sheet 
 
Identifying Information 
 
Study (document) identifier [StudyID]  
If multiple documents were used to code this study, indicate the supplemental study ID numbers 
Cross references document identifier [CROSREF1]  
Cross references document identifier [CROSREF2]  
Cross references document identifier [CROSREF3]  
Coder’s initials [Coder]  
Date coded [Date]  
Author:  [Author] 
Publication type [PubType]  
1   Book 4   Gov’t Report, State/local 
2   Book Chapter 5   Journal (peer reviewed) 
3   Gov’t Report, Federal 6   Unpublished (tech report, convention paper,    dissertation 
Year of publication:  
Number of different “modules” included in report [MODS]  
Is the same control/comparison group used in different 
modules? (1 = Yes; 0 = No) 
[SAME_CG]  
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Crime Prevention Meta-Analysis 
Treatment-Comparison Contrast Level Code Sheet 
 
A study may report on multiple independent evaluations, such as independent treatment and 
control group contrasts, or may have a design that includes multiple interventions of interest 
contrasted with a single control group.  Each of these treatment/control contrasts of interest is 
treated as a separate “module” for coding purposes.  Note that the treatment groups across 
modules must have independent (non-overlapping) subjects.  A single control group may be used 
in more than one module. 
 
Identifying Information 
 
Study (document) identifier [StudyID]  
Module identifier [ModID]  
Coder’s initials [CoderMod]  
 
Program Description 
 
Program description:                  [ProgDes 1] 
  
(text)  
 
 
Primary Treatment Type  [PrimeTx]  
1 Therapeutic Community (TC) 
2 Individual Counseling  
3 Group Counseling 
4 Boot Camp/Shock Incarceration 
5 Methadone Maintenance 
6 Multiple modes of treatment (specific modality depends on client characteristics) 
7 Other  
 
Treatment Components (Check all that apply) 
 Life skills  programs [TxComp1] 
 Cognitive behavioral programs [TxComp2] 
 12-step program [TxComp3] 
 Drug education [TxComp4]  
 Academic education  [TxComp5]  
 Post treatment aftercare component [TxComp6] 
 Other  [TxComp6] 
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In what format or social setting is the treatment delivered? [TxFormat]  
1 One-on-one (e.g., therapist/client) 
2 Group setting (e.g., classroom, group therapy) 
3 Family setting (e.g., family therapy) 
4 Mixed (i.e., any combination of the above) 
9 Cannot tell 
 
Where does the treatment group reside [TxLocale]  
1 Jail 4 Other CJ institution 
2 Prison 11 Mixed 
3 Halfway House  99 Other  
 
Who delivers or provides the treatment? [TxStaff]  
1 Mental health professionals 
2 CJ Professionals 
3 Professional educator 
4 Nonprofessional 
5 Other 
6 Cannot tell 
 
Length of primary intervention in months (weeks/4.3) 
a Minimum [TxMon1]  
b Maximum [TxMon2]  
c Mean [TxMon3]  
d Fixed (same for all subjects) [TxMon4]  
 
Length of aftercare or follow-up program component (weeks/4.3) [TxAfterM]  
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Describe the program for the comparison group if other than no              [ProgDes 2] 
treatment or treatment as usual. 
  
(text) 
 
What happens to the comparison group? [CompGrp]  
1 No treatment 
2 Wait-list control 
3 Placebo control or “strawman” alternative intervention 
4 Treatment as usual; management as usual 
5 Treatment drop-outs; unsuccessful participation 
6 Nonparticipation in program 
7 Mixed, any combination of above 
8 Non-sex-offender specific mental health treatment (sex-offender studies only) 
9 Cannot tell 
 
Where does the comparison group reside [CgLocale]  
1 Jail 4 Other CJ institution 
2 Prison 11 Mixed 
3 Halfway House  99 Other  
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Methodological Rigor 
 
Use of control variables in statistical analyses to account for 
initial group differences (1=Yes; 0 = No) 
[CntrlVar]  
Use of random assignment to conditions (1=Yes; 0 = No)  [Random]  
Use of subject level matching (1=Yes; 0 = No) [Matching]  
Measurement of prior criminal involvement; not necessarily 
arrest (1=Yes; 0 = No) 
[PreTest]  
 
Rating of initial group similarity (7=highly similar; 1=highly 
dissimilar) 
[SimRate]  
Anchors: 7 Randomized design large N or small N with matching 
 5 Nonrandomized design with strong evidence of initial equivalence 
 1 Nonrandomized design, comparison group highly likely to be different 
or known different that are related to future recidivism 
 
Was attrition discussed in the study reported? (1=Yes; 0 = No)   [Attrit1]  
 
Is there a potential generalizability threat from overall attrition? 
 
[Attrit2]  
0 No 8 N/A, no attrition problem 
1 yes 9 cannot tell 
 
Is there a potential threat from differential attrition?   [Attrit3]  
(same as above) 
 
Did the statistical analysis of outcome effects attempt to control for 
differential attrition effects? 
[Attrit4]  
(1=Yes; 0=No; 8=NA) 
 
Use of statistical significance testing (1=Yes; 0 = No)   [SigTest]  
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Maryland methodology rating (see Maryland scale) [MethScor]  
2 A comparison group is present but lacks comparability to the treatment group 
3 A comparison group is present but differs slightly from the program group 
4 A comparison group is present and it is very similar to program group, or a 
comparison group is present but it differs slightly from the program group, however, 
the data analysis controls for observed differences, or random assignment with large 
attrition 
5 Random assignment and analysis of comparable program and comparison groups, 
including controls for attrition 
 
 
Notes on Methodology 
 
(text) 
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Crime Prevention Meta Analysis 
Sample Level Code Sheet 
 
Since a study may report results separately for distinct samples, a sample is a separate “level” in 
the coding scheme.  For example if a study reports the results separately for  
 
Identifying Information 
 
Study (document) identifier [StudyID]  
Module identifier [ModID]  
Sample identifier (Note: each sample within a study gets a unique 
number) 
[SampID]  
Coder Initials [CoderSmp]  
 
Sample Description 
 
Sample description treatment group (location, level of security,              [SampDes1] 
prior history, etc.) 
 
     (Text) 
 
Sample description comparison group (location, level of security,                       [SampDes2] 
prior history, etc.) 
 
    (Text) 
 
Total number of individuals in treatment group at beginning of study [TxN]  
Total number of individuals in comparison group at beginning of study [CgN]  
Note: Above must equal the total sample size prior to any attrition.  If multiple samples per 
module are being coded, the sum across samples must equal the total sample size prior to any 
attrition. 
 
Approximate age range of study participants [Age]  
1 Adolescent (12 to 18)  4 Adolescent and young adult 
2 Young Adult (19 to 25)         5 Adolescent and adult 
3 Adult (18+)                            9 Unspecified or cannot tell 
 
Young age included in sample (99 if unknown) [YngAge]  
Oldest age included in sample (99 if unknown) [OldAge]  
Exact proportion of males in sample if reported [Males]  
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Approximate gender description of sample [Sex]  
1 All males (>90%) 
2 More males than females (60% to 90% males) 
3 Roughly half males and half females 
4 More females than males (60% to 90% females) 
5 All females (>90%) 
9 Cannot tell 
 
Offender type general categories [SampType]  
1 Violent, person crimes 
2 Nonviolent, nonperson crimes 
3 Mixed 
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Crime Prevention Meta-Analysis 
Outcome (DV) Level Code Sheet 
 
 
Identifying Information  
 
Study (document) identifier [StudyID]  
Outcome identifier (each coded outcome within a study gets a 
unique number) 
[OutID]  
Coder Initials [CoderDV]  
 
Outcome Information 
 
Outcome label (label used in report)        [label] 
 (text) 
 
Recidivism construct represented by this measure (1=Yes; 0 = No)   
a Arrest [DV1]  
b Conviction [DV2]  
c Reinstitutionalization / reincarceration [DV3]  
d Revocation [DV4]  
e Technical supervision violation [DV5]  
f Drug use [DV6]  
g Other indicator of criminal involvement [DV7]  
 
Specific types of offenses included in recidivism measure  (1=Yes; 0 = No)   
a All offenses [DVType1]  
b Drug offenses (including measures of drug use) [DVType2]  
c Person offenses, sexual [DVType3]  
d Person offenses, nonsexual [DVType4]  
e Person offenses, unspecified [DVType5]  
f Property offenses [DVType6]  
g Technical supervision or status offense [DVType7]  
h Other:  [DVType8]  
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Type of measurement scale [Scale]  
1 Dichotomy 3 4-9 discrete ordinal categories 
2 Tricotomy 4 >9 discrete ordinal categories or 
continuous 
Source of data [Source]  
1 Self-report 4 Other (e.g., urinalysis) 
2 Other report (e.g., teacher, parent) 9 Cannot tell 
3 Official record (e.g., school, police, probation, court, institution) 
 
 Is this a valid or reasonable measure of recidivism?  
(1 = questionable; 2 = acceptable) 
[Valid]  
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Crime Prevention Meta-Analysis 
Effect Size Level Code Sheet 
 
Identifying Information  
 
Study  identifier [StudyID]  
Module identifier  [ModID]  
Sample identifier [SampID]  
Outcome identifier [OutID]  
Effect size identifier (number each effect size within a study 
sequentially ) 
[ESID]  
Coder’s Initials [CoderES]  
 
Effect Size Information 
 
Effect size type [ES_Type]  
1 Baseline (pretest; prior to start of intervention) 
2 Post-test (first measurement point, post intervention) 
3 Follow-up (all subsequent measurement points, post intervention) 
 
Which group does the raw effect (difference) favor (ignoring 
statistical significance)? 
[ES_Direc]  
1 Treatment group 
2 Comparison group 
3 Neither (ES equal zero) 
9 Cannot tell (ES cannot be used if this option is selected) 
 
Is this difference reported as statistically significant by the 
investigator? 
ES_Sig]  
0 No 8 Not tested 
1 yes 9 Cannot tell 
 
Time frame in months captured by measure (weeks/4.3) 
a Minimum [ES_Time1]  
b Maximum [ES_Time2]  
c Mean [ES_Time3]  
d Fixed (same for all subjects) [ES_Time4]  
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Effect Size Data 
 
Treatment group sample size for this effect size [ES_TxN]  
Comparison group sample size for this effect size [ES_CgN]  
 
 
Treatment group mean (clearly indicate decimal point) [ES_TxM]  
Comparison group mean  (clearly indicate decimal point) [ES_CgM]  
Are the above mean adjusted? (1=Yes; 0 = No)   [ES_MAdj]  
 
 
Treatment group standard deviation (clearly indicate decimal point) [ES_TxSD]  
Comparison group standard deviation  (clearly indicate decimal 
point) 
[ES_CgSD]  
Treatment group standard error (clearly indicate decimal point) [ES_TxSE]  
Comparison group standard error  (clearly indicate decimal point) [ES_CgSE]  
 
 
Treatment group; number successful [ES_TxNS]  
Comparison group; number successful [ES_CgNS]  
Treatment group; proportion successful [ES_TxPS]  
Comparison group; proportion successful [ES_CgPS]  
Are the above proportion adjusted for initial group nonequivalence? 
(1=Yes; 0 = No)   
[ES_PAdj]  
 
t-value from an independent t-test or square root of F-value from a 
one-way analysis of variance with one df in the numerator (only two 
groups) 
[ES_T]  
 
Exact probability for a t-value from an independent t-test or square 
root of F-value from a one-way analysis of variance with one df in the 
numerator (only two groups) 
[ES_T_P]  
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Chi-square value with df = 1 (2 by 2 contingency table)   [ES_ChiSQ]  
 
Correlation coefficient (point biserial) [ES_RPB]  
 
Correlation coefficient (phi) [ES_RPHI]  
Computer Calculated ES [ES]  
Hand Calculated ES [HAND_ES]  
Hand Calculated SE of ES [HAND_SE]  
 
 
 
 
